Transplantation of epithelia derived from keratinocyte stem cells transduced by retroviral vectors is a potential therapy for epidermolysis bullosa (EB), a family of inherited skin adhesion defects. The biosafety characteristics of retroviral vectors in keratinocytes are, however, poorly defined. We developed self-inactivating (SIN) vectors derived from the Moloney murine leukemia (MLV) and the human immunodeficiency (HIV) viruses expressing therapeutic levels of LAMB3, a transgene defective in junctional EB, and tested their integration profile in human primary keratinocytes. The SIN-HIV vector showed the expected preference for transcribed genes while the SIN-MLV vector integrated preferentially in regulatory elements, but showed a significantly lower tendency to target cell growth-related genes, transcription start sites and epigenetically defined promoters compared with a wild-type MLV vector in an epithelial cell context. A quantitative gene expression assay in individual keratinocyte clones showed that MLV-derived vectors deregulate expression of targeted genes at a lower frequency than in hematopoietic cells, and that the SIN-MLV design has the lowest activity compared to both MLV and SIN-HIV vectors. This study indicates that SIN-MLV vectors may have a better safety profile in keratinocyte than in hematopoietic cells, and be a reasonable alternative to lentiviral vectors for gene therapy of inherited skin disorders.
INTRODUCTION
Epidermolysis bullosa (EB) is a family of autosomal recessive skin adhesion disorders caused by impairment of the epidermaldermal junction, presenting at birth with severe, disfiguring blistering and erosions. 1 Preclinical studies carried out in recent years showed that genetically corrected epidermal stem cells (EpSCs) are able to regenerate a healthy epidermis, thus providing a potential cure for EB and other genetic skin diseases. 2, 3 Junctional EB (JEB) is mainly caused by mutations in any of the three genes (LAMA3, LAMB3, LAMC2) encoding the a 3 , b 3 or g 2 chains of the basement membrane adhesion ligand laminin-332, a key component of hemidesmosomes. 1 A pilot clinical trial carried out on a patient affected by laminin-332 b 3 -chain-deficient JEB showed that transplantation of autologous cultured epidermis derived from genetically corrected EpSCs leads to long-term functional correction of the skin adhesion defect. 4 In that study, however, EpSCs were transduced with a retroviral vector derived from the Moloney murine leukemia virus (MLV), which caused severe adverse events in patients undergoing gene therapy for primary immunodeficiencies [5] [6] [7] [8] and would be unsuited for full clinical development of gene therapy of JEB. We had previously developed an HIV-derived self-inactivating (SIN) lentiviral vector for the expression of LAMB3 complementary DNA (cDNA) under the control of the basal keratinocyte-specific keratin 14 (K14) enhancer/promoter element, and showed its ability to correct the genetic adhesion defect in a preclinical model of transplantation of EpSC-derived skin equivalents. 9 Although SIN-HIV vectors have showed a favorable genotoxic profile compared to MLV and SIN-MLV vectors, [10] [11] [12] [13] they raised concerns for their potential to cause post-transcriptional deregulation of gene expression. [14] [15] [16] [17] [18] The genotoxic potential of MLV vectors derives from the longdistance, cis-acting activity of the long terminal repeat (LTR) U3 enhancer combined to a target site selection mechanism that privileges integration around transcription start sites (TSSs) and transcriptional regulatory elements. [19] [20] [21] A U3-deleted, SIN design, and the use of cellular enhancer elements to drive transgene expression, reduce the genotoxicity of MLV vectors in preclinical models, [10] [11] [12] [13] and are expected to decrease the chances of causing insertional oncogenesis in patients' repopulating cells. In this study, we report the characterization of a SIN-MLV vector expressing a LAMB3 cDNA under the control of the K14 enhancer/ promoter, which is able to drive LAMB3 expression at physiological levels and restore synthesis and secretion of laminin-332 in keratinocyte cultures derived from a JEB patient. To analyze the genotoxic characteristics of a SIN-MLV design, we defined the integration profile in human primary keratinocytes of an MLV vector and a SIN-MLV and a SIN-HIV vector carrying the same K14-driven expression cassette. The SIN-MLV vector showed an unexpectedly lower tendency to integrate in proximity of TSSs and promoters compared with a full-LTR MLV vector, and a lower propensity to deregulate gene expression compared with both MLV and SIN-HIV vectors in an epithelial cell context. SIN-MLV vectors may therefore represent a reasonable alternative to SIN-HIV vectors for gene therapy of JEB.
RESULTS
A SIN-MLV vector corrects the LAMB3 defect in JEB keratinocytes SIN-MLV vectors expressing enhanced green fluorescence protein (EGFP) (SIN-MLV.K.G vector) or a LAMB3 cDNA (SIN-MLV.K.B3 vector) under the control of the full-length K14 promoter 9 were constructed in the SRS11 vector backbone 22 ( Figure 1a ). Both vectors were pseudotyped with the vesicular stomatitis virus G protein and used to infect human foreskin primary keratinocytes at a multiplicity of infection (MOI) of 1, 5 and 10. The transduction efficiency of the SIN-MLV.K.G vector was compared with that of the SIN-HIV.K.G vector, a lentiviral vector previously shown to drive the expression of the LAMB3 cDNA in the basal layer of the epidermis and correct the JEB adhesion defect in vivo. 9 At MOI 10, the SIN-MLV.K.G and SIN-HIV.K.G vectors transduced B50% and B80% respectively of cultured keratinocytes as analyzed by cytofluorimetry, with an average vector copy number (VCN) per transduced cell of 2.3 and 6.4, respectively, as determined by quantitative PCR on bulk cell populations (data not shown).
To examine the capacity of the SIN-MLV.K.B3 vector in restoring laminin-332 synthesis and correcting the JEB cell phenotype, we transduced primary keratinocytes derived from a patient affected by a lethal form of LAMB3-deficient JEB. These cells harbor two null LAMB3 alleles, are unable to synthesize heterotrimeric laminin-332, have a decreased colony-forming capacity, and give rise to skin cultures with impaired adhesion properties. Subconfluent keratinocytes were cultured onto a feeder layer of lethally irradiated 3T3-J2 cells, and transduced with the SIN-MLV.K.B3 and the SIN-HIV.K.B3 vector at an MOI of 10. Immunofluorescence analysis of cytoplasmic LAMB3 showed a transduction efficiency of B30% for SIN-MLV.K.B3 and B60% for SIN-HIV.K.B3, with an average VCN per transduced cell of 1.8 and 3.9, respectively, as assayed by quantitative PCR. Southern blot analysis of genomic DNA restricted with KpnI showed that cells transduced with the SIN-MLV vector contain a stably integrated provirus of the expected size (Figure 1b) . Western blot analysis of cytoplasmic and secreted laminin-332 on whole-cell lysates or culture medium with antibodies specific for the b3 and g2 chains showed that the SIN-MLV.K.B3 vector is able to restore full expression of b3 chain and proper assembly and secretion of laminin-332, as indicated by the presence of both b3 the chain and the processed, 105-kDa form of the g2 chain (Figure 1c) . The expression level of the b3 protein mediated by the SIN-MLV vector was comparable to that mediated by the SIN-HIV vector, after VCN normalization, and to that of the endogenous LAMB3 gene in control keratinocytes from a healthy donor (Figure 1c) . These results show that the SIN-MLV.K.B3 vector is genetically stable and corrects the biochemical defect of LAMB3-deficient JEB keratinocytes at low VCN by restoring physiological synthesis and secretion of laminin-332.
Analysis of the integration profile of MLV, SIN-MLV and SIN-HIV vectors in human primary keratinocytes In order to compare the integration profiles of all potential candidate vectors for gene therapy of JEB, we transduced normal human primary keratinocytes with the SIN-MLV.K.G vector, the SIN-HIV.K.G vector, and a wild-type LTR-based MFG vector 4 (wt-MLV). DNA was extracted four (wt-MLV and SIN-MLV) or fourteen (SIN-HIV) days after infection, and integration sites mapped by linear amplification-mediated PCR for both MLV-derived vectors and linear amplification-mediated PCR and ligation-mediated PCR for the SIN-HIV vector, followed by pyrosequencing. A total of 819, 1307 and 1743 (of which 381 by ligation-mediated PCR) integrations were mapped for the SIN-MLV, wt-MLV and SIN-HIV vector, respectively. As a control data set, we used 40 000 sites sampled from a library of 11 655 601 weighted, random genomic sequences. 20 Integration and random sites were mapped on the University of California Santa Cruz hg18 release of the human genome, 23 and annotated as TSS-proximal when occurring in an interval of ± 2.5 kb from the TSS of any Known Gene (University of California Santa Cruz definition), intragenic when occurring inside a Known Gene 42.5 kb from the TSS, and intergenic in all other cases. All genes whose TSS mapped in a ± 50-kb window from each site were annotated and considered as 'target' genes. Table 1 ). The reduced clustering in TSS-proximal regions of the SIN-MLV vector is evident when integration sites are plotted around TSSs at 500-bp resolution (Figure 2) . Interestingly, the same wt-MLV and SIN-MLV vectors showed virtually identical integration profiles in human primary hematopoietic stem/ progenitor cells (Table 1) .
A SIN-MLV vector targets epigenetically defined promoters at a lower frequency than a wt-LTR MLV vector in human keratinocytes We next evaluated the association between vector integration sites and epigenetic signatures identifying active regulatory regions (enhancers, promoters), by taking advantage of publicly available chromatin immunoprecipitation sequencing (ChIP-seq) data from primary human keratinocytes produced by the ENCODE consortium. 24 These data are categorized to specify nine different chromatin state domains on the basis of the presence/absence of specific histone modifications (for example, H3K4me1, H3K4me2, H3K4me3, H3K36me3, H3K27me3 and H3K27ac) and in particular active promoters, enhancers, transcribed regions, heterochromatin and chromatin repressed by polycomb-group factors. For each vector type, we evaluated the proportion of integration sites falling in each defined chromatin domain through association with their respective genomic coordinates ( Figure 3a ). Almost 100% of the integrations sites of all vector types were univocally associated to a chromatin state. In particular, 15.4% (201) of wt-MLV integrations were associated to promoters, 69.5% (909) to enhancers, 8.9% (116) to transcribed regions, 0.2% (3) to polycomb-group-repressed regions and 5.6% (73) to heterochromatin. A similar pattern was observed for the SIN-MLV vector, with 6.2% (51) of integration sites hitting promoters, 70.8% (580) enhancers, 12.6% (103) transcribed regions, 0.8% (7) polycomb-group-repressed and 8.9% (73) heterochromatic regions. Both MLV-derived vectors showed an overrepresentation of integrations in promoter and enhancer regions compared with random controls (1.2% in promoters and 5.5% in enhancers, Po10 À 16 , w 2 -test), with a striking preference for enhancers. However, the SIN-MLV vector showed a decreased preference for epigenetically defined promoters (6.2% vs 15.4%, Po10 À 10 ) and an increased association to transcribed regions (12.6% vs 8.9%, Po0.006) and heterochromatin (8.9% vs 5.6%, Po0.003) (Figure 3a) . The different preference for promoters between the two vectors is highlighted when the average ChIP-seq read densities of the single histone modifications are plotted around each wt-MLV and SIN-MLV integration site. While the distribution profiles of H3K4me1, H3K36me3 and H3K27me3 histone modifications, enriched in enhancers, transcribed regions and heterochromatin, respectively, are almost identical between the two vectors, the density of H3K4me3 signals, the main epigenetic marker of promoters, apparently diminishes around SIN-MLV integration sites ( Figure 3b ). The SIN-HIV vector showed a very different pattern with respect to the MLV-derived vectors, in line with its divergent integration preferences. Only 0.9% (14) and 7.7% (123) respectively of the SIN-HIV integrations associated to epigenetically defined promoters and enhancers, a negligible difference compared with random controls. The SIN-HIV vector showed instead a very high propensity for integrating in actively transcribed regions (62.9%) compared with both random controls and to MLV-derived vectors (Po10 À 16 in all cases) ( Figure 3a) .
Genes involved in cell growth and development are targeted at low frequency by a SIN-MLV vector To correlate vector integration with gene activity, we determined the expression profile of 18,862 genes by Affymetrix microarray analysis in mock-transduced human primary keratinocytes derived from three different healthy donors. Expression data where Abbreviations: HSPC, hematopoietic stem/progenitor cells; MLV, Moloney murine leukemia; SIN, self-inactivating; TSS, transcription start site. generated using the GeneAnnot-based Chip Definition File (CDF), which includes in a unique custom probe set only probes matching transcripts unequivocally associated to a gene, thus avoiding the multi-transcripts mapping redundancy of Affymetrix probe sets. 25 The wt-MLV and SIN-MLV vectors showed a similar trend, with B70% of the targeted genes scored as active at the time of infection compared with B55% of the randomly targeted genes (Po10 À 16 ), with no significant differences between intergenic, intragenic and TSS-proximal integrations. SIN-HIV vector showed a higher propensity for active genes (475%, Po10 À 16 ), in particular for the intragenic integrations ( Figure 4a ). We next defined the functional categories overrepresented in the group of genes hit by the different vectors by using the Ingenuity Pathway Analyses software (Figure 4b ). Functional categories related to the control of growth, proliferation, death and movement of epithelial cells were overrepresented in wt-MLV target gene lists compared with random controls (Po10 À 16 ). The SIN-MLV vector showed a similar enrichment compared to controls, but with a strikingly lower percentage of genes in each category compared with the wt-MLV (10 À 12 oPo0.0004). On the contrary, the only molecular functions enriched in the genes targeted by the SIN-HIV vector compared with controls were cell cycle and cell death, although with a lower number of genes with respect to the wt-MLV vector (Figure 4b) .
We extended the analysis to genes annotated as cancer-related proto-oncogenes and retroviral common insertion sites (CIS) (see Methods for definitions and data source): wt-MLV integrations targeted 127 proto-oncogenes and 64 CIS, (9.7% and 4.9% of the integration sites, respectively), a significant overrepresentation compared to random controls (Po10 À 15 ). The same frequencies were obtained when investigating SIN-MLV target genes, with 41 (5%) CISs and 80 (9.7%) proto-oncogenes hit by integration events, while only proto-oncogenes were overrepresented in the SIN-HIV data set (7.7%) (Figure 4c) . We further considered a subgroup of 164 proto-oncogenes that have been linked to the onset of epithelial tumors. None of the vectors exhibited preferences in targeting epithelial proto-oncogenes, which represented only 1.9% of both wt-MLV and SIN-MLV integrations and 1.2% of SIN-HIV integrations, resulting in a negligible difference compared with random controls (0.8%, P40.1) (Figure 4c ).
Analysis of integration-mediated deregulation of gene expression by MLV, SIN-MLV and SIN-HIV vectors
To determine the propensity of the wt-MLV, SIN-MLV and SIN-HIV vectors to deregulate the expression of genes in an epithelia cell context, we used a previously described quantitative assay that detects changes in the expression of genes surrounding the integration sites in individual, randomly selected cell clones. 26, 27 Human HaCaT keratinocytes were transduced with the three vectors and cloned by limiting dilution. Vector integration sites were mapped from randomly selected GFP þ clones by ligationmediated PCR and Sanger sequencing. RNA was extracted from each clone and the expression of all Known Genes whose TSS was within a window of ±50 kb from an insertion site determined by Table 2 and Supplementary Table S1 . The expression level of each target gene in HaCaT cells was also derived from publicly available Affymetrix microarray data, and color-coded as absent, low, intermediate or high in Figure 5b . Up and downregulated genes were found for all vector types at different frequencies. The wt-MLV vector induced perturbation in the expression of 5/123 tested genes (4.1%), the SIN-MLV.K.G vector in 6/86 genes (6.9%) and the SIN-HIV.K.G vector in 11/178 genes (6.2%). The frequency of upregulation was higher for the wt-MLV vector (5/6 perturbed genes) compared with the SIN-MLV (2/6 genes) and HIV (3/11) vectors (Table 2 and Supplementary  Table S1 ). To improve the robustness of the analysis, P-values were corrected for false discovery rate by the Bonferroni method, which confirmed significant (Po0.05 after correction) upregulation of two genes for the wt-MLV vector (1.6%), one for the SIN-MLV vector (1.1%) and one for the SIN-HIV vector (0.6%) ( Figure 5b and Table 2 ). The SIN-HIV vector confirmed the tendency to downregulate the expression of target genes already seen in hematopoietic cells, 18, 26 causing a two to sevenfold decrease in the expression of 5 out of 118 cases (4.2%) in which the vector integrated in the transcribed portion of the gene ( Figure 5b and Table 2 ).
DISCUSSION
Genome-wide analysis of retroviral integration sites revealed that each retrovirus type has a unique, characteristic pattern of integration in mammalian genomes. 19 In human cells, MLV and its derived vectors integrate preferentially in transcriptionally active promoters and regulatory regions, 20 while HIV and its derived lentiviral vectors target gene-dense regions and the transcribed portion of expressed genes, away from regulatory elements. 20, 28, 29 Recent clinical studies have shown that insertional activation of proto-oncogenes by MLV-derived vectors caused T-cell lymphoproliferative disorders in patients undergoing gene therapy for X-linked severe combined immunodeficiency 7, 8 and Wiskott-Aldrich syndrome, 30 and premalignant expansion of myeloid progenitors in patients LRRC28  COL15A1  BRP44  STS  GRK5  ANKRD22  MAT2B  SNX24  TUBGCP5  TM4SF18  ANXA1  DHX30   12 treated for chronic granulomatous disease. 6, 31 Activation of protooncogenes induced by the transcriptional enhancers present in the MLV LTR had a major role in the establishment/progression of these oncogenic events. HIV-derived SIN lentiviral vectors are expected to have a more favorable safety profile, given the absence of viral enhancers in their LTRs and their tendency to integrate far from cellular regulatory elements. However, preclinical and clinical studies showed that lentiviral vectors may cause alterations of gene expression at the posttranscriptional level, by inducing aberrant splicing and readthrough transcription at a relatively high frequency. [14] [15] [16] 18, 26 Most of these studies have been carried out in hematopoietic cells and very little is known of the potential genotoxicity of MLV-and HIV-derived vector in an epithelial context, an important information in view of the clinical use of genetically corrected EpSCs.
In this study, we have attempted to define the genotoxic profile of MLV-and HIV-derived vectors in human primary keratinocytes. In particular, we tested both wt-LTR and SIN-MLV vectors, since the latter were shown to be less prone to insertional oncogenesis and cell immortalization in preclinical assays. 10, 13, 26, 32 All three vector types were able to correct phenotypically a LAMB3-deficient JEB mutation in cell culture, by expressing a LAMB3 transgene under the control of either the LTR (MLV vector) or an internal, keratinocyte-specific K14 enhancer/promoter (SIN-MLV and SIN-HIV vectors). Analysis of the integration profile showed the expected pattern for the MLV and the SIN-HIV vectors, respectively biased for regulatory elements and transcribed genes. Interestingly, the SIN-MLV vector showed a different profile, with a significantly lower bias for TSSs and promoters, defined by histone modifications signatures in the keratinocyte genome. The MLV U3 enhancer contains binding sites for cellular factors that may have a role in tethering retroviral preintegration complexes to transcriptionally active regulatory regions, 33 and its removal might, therefore, be expected to change the vector integration preferences. However, we recently showed that MLV and SIN-MLV have a virtually identical integration profile in human hematopoietic stem/ progenitor cells, where they target the same integration hot spots at virtually the same frequency. 34 The present data, therefore, suggest that target site selection of SIN-MLV vectors may have cell-specific components, which in an epithelial cell context require the U3 enhancer to target RNA PolII promoters and TSS-proximal regions at high efficiency. On the contrary, targeting of enhancers, again defined by epigenetic signatures, appears unaffected by the U3 deletion.
A functional clustering analysis of the genes targeted by the three vector types uncovered other cell-specific characteristics of retroviral integration patterns. Although MLV-derived vectors show a significant propensity for integrating within or around genes involved in the control of cell proliferation, differentiation and death, they target these classes of genes at a significantly lower frequency compared with hematopoietic stem/progenitor cells and T-lymphocytes. 28, 35, 36 Similarly, proto-oncogenes and cancerrelated CISs are targeted at about half the frequency in epithelial cells (o10%) compared with hematopoietic cells, although some of the gene lists used for this analysis, and particularly the RTCGD database, might be biased for blood cell-specific oncogenes. Perhaps more importantly, proto-oncogenes involved in skinrelated malignancies, which might potentially induce neoplasia if activated by retroviral insertion, are not significantly targeted by MLV vectors, suggesting that the risk of insertional oncogenesis might be significantly reduced in an epithelial vs a hematopoietic cell context, where MLV targets leukemia/lymphoma-related protooncogenes at high frequency. Interestingly, the SIN-MLV vector showed a significantly reduced frequency in targeting all classes of growth-related genes compared with a wt-MLV vector in the epithelial cell context, indicating again a role for the U3 enhancer in determining subtle components of the MLV integration preferences in a cell-specific fashion.
The potentially safer integration profile of MLV vectors in keratinocytes is reflected by the frequency of up and downregulation of the expression of genes in a ± 50-kb window around the integration site, as determined by quantitative PCR in a clonal assay in human HaCaT keratinocytes. We observed that the frequency of upregulation events caused by both MLV vectors is sensibly lower compared to what we had previously observed by the same assay in human hematopoietic cells (o2 vs 5-12%), 26, 27, 37 suggesting that MLV vectors might have a lower propensity to activate proto-oncogenes in keratinocytes. Unfortunately, the absence of specific transformation assays for this type of cells does not allow to directly testing this hypothesis in culture or in vivo. On the contrary, the frequency of downregulation of gene expression caused by insertion of a SIN-HIV vector is perfectly comparable to those observed in hematopoietic cells (45%), 26, 34 an expected result given the posttranscriptional nature of this type of events and the comparable frequency by which HIV vectors target gene bodies in epithelial and hematopoietic cells.
A final consideration concerns the average VCN per transduced cell of MLV vs HIV vectors. In cultured keratinocytes, SIN-HIV vectors tend to insert many more proviruses per transduced cell that MLV vectors, particularly at high MOIs, as shown in this and previously published studies, 9,14 a non-negligible issue in terms of biosafety. On the contrary, MLV vectors integrate at a low copy number in keratinocytes, similarly to what observed in hematopoietic and other human cell types. All together, these data indicate that MLV-derived retroviral vectors may have a significantly better safety profile in keratinocytes than in hematopoietic cells, and that a SIN-MLV vector, deprived of its strongly activating U3 enhancer and targeting promoters at a much lower frequency than a full-LTR vector, might be a very reasonable alternative to SIN-HIV vectors for clinical applications.
MATERIALS AND METHODS

Vector construction and packaging
The SIN-MLV.K.G and SIN-MLV.K.B3 vectors were built in the framework of the pSRS11.EFS.GFP vector (a kind gift from C. Baum). In the SIN-MLV.K.G vector, the EFS promoter was replaced by an AvaI fragment containing the 2.1-kb promoter/enhancer of the human K14 promoter. 38 To construct the SIN-MLV.K.B3 vector, the EGFP gene from the SIN-MLV.K.G vector backbone was replaced by a ClaI-SalI fragment encoding the full-length LAMB3 cDNA.
Viral stocks pseudotyped with the vesicular stomatitis G protein (VSV-G) were prepared by transient co-transfection of 293T cells using a threeplasmid system (the transfer vector, the pCMVDR8.74 plasmid encoding Gag, Pol, Tat and Rev, and the pMD.G plasmid encoding VSV-G for the SIN-HIV vector, or the pMG plasmid encoding Gag and Pol and the pMD.G plasmid for the MLV vectors), as previously described. 39 Viral preparations were concentrated by ultracentrifugation to increase titer. Viral titers were determined by transduction of HeLa cells with serial dilution of the vector stocks in the presence of 8 mg ml 
Southern blot analysis
Genomic DNA was extracted from 1-5 Â 10 6 cells by a QIAmp DNA Mini Kit (Qiagen, Valencia, CA, USA), digested overnight with AflII, run in 10 mg aliquots on a 0.8% agarose gel, transferred to a nylon membrane (Duralon, Stratagene, La Jolla, CA, USA) by Southern capillary transfer, and probed with 2 Â 10 7 c.p.m.
32
P-labeled WPRE probe, according to standard techniques. 40 Western blot analysis Subconfluent cells were incubated in serum-free medium for 24-48 h at 37 1C. The medium was collected, concentrated by membrane filtration (Amicon Ultra-4, '50 000 molecular weight cutoff', Millipore, Billerica, MA, USA) and frozen. Cells were lysed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% deoxycolate, 1% Triton X-100, 0.1% SDS, 0.2% sodium azide, pH 7.5 containing protease inhibitors) for 30 0 on ice, and protein amount determined by Bradford assay (Bio-Rad, Hercules, CA, USA). Medium and cell lysate samples (40-50 mg) were run on a 6% SDS-PAGE (80 V, 2-3 h.) gel, transferred onto polyvinylidene fluoride filters (Immobilon-P, Millipore) and immunoblotted (100 mA at 4 1C, overnight) using either a polyclonal antibody against the human LAM5 b3-chain (anti-Kalinin B1 clone 17, 1:1000, BD Biosciences, Franklin Lakes, NJ, USA) or a mouse monoclonal antibody against the LAM5 g2 chain (clone D4B5, 1:100, Millipore). Protein detection was carried out using a chemiluminescent labeling detection reagent (ECL, GE Healthcare, Milan, Italy).
Immunofluorescence
Transduced HeLa cells or keratinocytes were plated at clonal density (1000 to 10 000 cells). Seven to 10-day-old colonies were fixed (3% paraformaldehyde/2% sucrose in phosphate-buffered saline, pH 7.6) and analyzed for LAMB3 expression using a LSM510 confocal microscope (Zeiss, Oberkochen, Germany). Cells were permeabilized (0.5% Triton X-100 in phosphate-buffered saline), coated with 0.5% BSA/phosphate-buffered saline for 1 h at room temperature, and incubated with a 1:100 dilution of a goat polyclonal antibody against human LAMB3 (anti-Kalinin B1 clone 17, 1:200, BD Biosciences) overnight at 37 1C followed by a 60 0 incubation at room temperture with a 1:100 dilution of a rhodamine-conjugated or fluorescein isothiocyanate-conjugated secondary antibody.
Integration site analysis
Integration sites were cloned from bulk cultures or individual HaCaT clones by ligation-mediated PCR or linear amplification-mediated PCR, as previously described. 20, 41 Crude sequence reads were processed and mapped onto the human genome by an automated bioinformatics pipeline. 20 A valid integration contained the MLV or HIV nested primer, the MLV or HIV 3 0 -LTR sequence up to the CA dinucleotide, and the linker nested primer. Sequences between the 3 0 -LTR and the linker were mapped onto the human genome (University of California Santa Cruz Human Genome Project Working Draft, hg18) using Blat sequence alignment tool, requiring a 95% identity over the entire sequence length and selecting the best hit. The absolute genomic coordinates of the integration sites where defined as a result of the combination of genomic alignment and vector relative orientation data. All University of California Santa Cruz Known Genes 42 having their TSS at ± 50 kb from an integration site were annotated as targets. Epigenetic features were annotated when their genomic coordinates overlapped for at least one nucleotide the vector integration site. A matched, random control data set was generated as previously described. 20 For all pair-wise comparisons, we applied a two-sample test for equality of proportions with continuity correction with the use of the Rweb 1.03 statistical analysis package (http:// www.math.montana.edu/Rweb/).
Gene expression profiling
The expression profile of primary keratinocytes was determined by microarray analysis. RNA was isolated from 1-2 Â 10 6 primary keratinocytes, transcribed into biotinylated cRNA and hybridized to Affymetrix HG-U133A Gene Chip arrays according to the Affymetrix instructions. The arrays were reannotated with a set of previously described custom Chip Definition Files and the corresponding Bioconductor libraries. 25 Microarray profiles for HaCaT cells have been published previously 43 and analyzed with the same pipeline used for keratinocytes microarrays starting from deposited CEL files. To correlate retroviral integration and gene activity, expression values from the keratinocytes microarrays were classified as absent, low (o25th percentile of the normalized distribution), intermediate (25th to 75th percentile) and high (475th percentile).
Functional clustering analysis
To search for significant functional clusters among genes targeted by viral integrations, a gene-enrichment analysis was performed using Ingenuity pathways analysis tool (Ingenuity Systems, http://www.ingenuity.com). A Fisher's Exact test with Bonferroni correction for multiple testing is adopted to measure the level of gene-enrichment in gene ontology (GO) annotation terms with respect to a background population. To correlate viral integration with cancer-related genes, a list of 596 human protooncogenes was compiled from the University of New South Wales Quantitative analysis of gene expression perturbation Transduced HaCaT cell populations were cloned by limiting dilution in 96-well plates at a concentration of 0.3 cells per well by automated cell sorting. Total RNA (100 ng) was extracted from individual clones and reverse transcribed using the cDNA Archive kit (Applied Biosystems). TaqMan PCR reactions were carried out onto custom 7900 TaqMan lowdensity arrays ('Assay on Demand', Applied Biosystems) on an ABI PRISM 7900 HT system (Applied Biosystems). Gene expression levels were determined as previously described, 26 using the comparative CT method of relative quantification. P-values were corrected for false discovery rate by the Bonferroni method.
